Evidence map›Paper›PMID 26698606›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2016

Improved ex vivo blood compatibility of central venous catheter with noble metal alloy coating.

Manijeh Vafa Homann, Dorota Johansson, Håkan Wallen, Javier Sanchez

Open access · hybridAbstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Blood-Contacting Biomaterials:Frontiers in bioengineering and biotechnology · 2018
    Review
  8. Improved ex vivo blood compatibility of central venous catheter with noble metal alloy coating.Journal of biomedical materials research. Part B, Applied biomaterials · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Manijeh Vafa HomannInfectious Disease Unit, Karolinska University Hospital, Stockholm, Sweden.
Dorota JohanssonResearch and Development Department, Bactiguard AB, Stockholm, Sweden.
Håkan WallenDivision of internal and Cardiovascular Medicine, Department of Clinical Science Danderyd Hospital, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
Javier SanchezResearch and Development Department, Bactiguard AB, Stockholm, Sweden. javier.sanchez@bactiguard.se.
Bactiguard (Sweden) · SEDanderyds sjukhus · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central line associated bloodstream infections (CLABSIs) are a serious cause of morbidity and mortality induced by the use of central venous catheters (CVCs). Nobel metal alloy (NMA) coating is an advanced surface modification that prevents microbial adhesion and growth on catheters and thereby reduces the risk of infection. In vitro microbiological analyses have shown up to 90% reduction in microbial adhesion on coated CVC compared to uncoated ones. This study aimed to assess the blood compatibility of NMA-coated CVC according to ISO 10993-4. Hemolysis, thrombin-antithrombin (TAT) complex, platelet counts, fibrin deposition, and C3a and SC5b-9 complement activation were analyzed in human blood exposed to the NMA-coated and control CVCs using a Chandler-loop model. NMA-coated CVC did not induce hemolysis and fell in the "nonhemolytic" category according to ASTM F756-00. Significantly lower amounts of TAT were generated and less fibrin was deposited on NMA-coated CVC than on uncoated ones. Slightly higher platelet counts and lower complement markers were observed for NMA-coated CVC compared to uncoated ones. These data suggest that the NMA-coated CVC has better ex vivo blood compatibility compared to uncoated CVC. © 2015 The Authors Journal of Biomedical Materials Research Part B: Applied Biomaterials Published by Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1359-1365, 2016.

Indexed as

Central Venous CathetersMaterials TestingAdultAlloysBlood PlateletsBlood ProteinsFemaleHumansMaleAlloysBlood Proteinsblood compatibilitycentral line associated blood stream infectioncentral Venous catheternobel metal alloy coatingsurface modification

Identifiers

PMID26698606
PMCPMC5054833
OpenAlexW1593332351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.